Hainan Poly Pharm. Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China and internationally. The company's dosage formulations comprise of tablets, capsules, granules, ointments, eye drops, pre-infusion, injection, lyophilization, and oral solutions. It also offers pharmaceutical preparations, active pharmaceutical ingredients, other raw materials, excipients, prescription drugs, and contract manufacturing and contract development and manufacturing services. Hainan Poly Pharm. Co., Ltd. was founded in 1992 and is headquartered in Haikou, China.
Research context
Hainan Poly Pharm. Co., Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Hainan Poly Pharm. Co., Ltd is currently in a long term uptrend where the price is trading 5.8% above its 200 day moving average.
From a valuation standpoint, the stock is 120.1% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 21.2.
Hainan Poly Pharm. Co., Ltd's total revenue rose by 48.2% to $380M since the same quarter in the previous year.
Its net income has increased by 47.1% to $126M since the same quarter in the previous year.
Finally, its free cash flow fell by 83.3% to $-65M since the same quarter in the previous year.
Based on the above factors, Hainan Poly Pharm. Co., Ltd gets an overall score of 3/5.